A Trial of Cooled Radiofrequency Ablation of Medial Branch Nerves for theTreatment of Lumbar Facet Syndrome
STU00097239
A Prospective Trial of Cooled Radiofrequency Ablation of Medial Branch Nerves for the Treatment of Lumbar Facet Syndrome
1 other identifier
interventional
48
1 country
1
Brief Summary
This study is being done to determine whether cooled radiofrequency ablation (CRFA) on the medial branch nerves of the lumbar facet joint is effective for the treatment of low back pain. CRFA blocks the nerves that carry pain signals from joints in the lower back such that the brain does not receive the message that the low back is in pain. This technique is commonly performed by burning these nerves rather freezing them, but it is suspected that freezing them results in better pain relief. The CRFA blocks has been shown to effectively treat sacroiliac joint pain (a joint in the pelvis), which is another reason that it is suspected that CRFA will be effective when treating pain related to facet joints in the low back. We are performing this study in order to determine if that is the case.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_3 low-back-pain
Started Jun 2015
Typical duration for phase_3 low-back-pain
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2015
CompletedFirst Submitted
Initial submission to the registry
June 17, 2015
CompletedFirst Posted
Study publicly available on registry
June 23, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2018
CompletedSeptember 6, 2018
September 1, 2018
3.2 years
June 17, 2015
September 5, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pain improvement
Percent of participants who reported 50% or greater improvement in pain
6 months post-procedure
Secondary Outcomes (4)
Global pain score
1 month, 3 months, 6 months and 12 months post procedure
McGill Pain Questionnaire (MPQ)
1 month, 3 months, 6 months and 12 months post procedure
Pain Anxiety Symptom Scale short form (PASS-20)
1 month, 3 months, 6 months and 12 months post procedure
Center for Epidemiologic Studies Depression short form index (CESD-10)
1 month, 3 months, 6 months and 12 months post procedure
Study Arms (2)
Group 1
ACTIVE COMPARATORConventional radiofrequency ablation (RFA) Following ablation, 0.5 cc of 0.5% bupivacaine will be injected to provide post procedure analgesia.
Group 2
ACTIVE COMPARATORCooled radiofrequency ablation (CRFA) Following ablation, 0.5 cc of 0.5% bupivacaine will be injected to provide post procedure analgesia.
Interventions
A conventional RFA electrode with a 10mm active tip will be used. RFA lesions will be performed for 90 seconds with the maximum electrode temperature raised to 80°C.
Following 18G C-RFA electrode positioning, 1cc of 2% lidocaine will be injected through the introducer needle for anesthesia during the ablation. The maximum electrode temperature is 60°C.
Eligibility Criteria
You may qualify if:
- Patients with lumbar facet syndrome pain who would undergo treatment by lumbar medial branch radiofrequency ablation.
- Low back pain for at least 6 months.
- Pain resistant to conventional therapy including NSAIDs, opioids, muscle relaxants, oral steroids, physical therapy or chiropractic care.
- Pain diagram suggesting possibility of facet-mediated pain.
- Referred pain when present not beyond the knee.
- Positive response to at least 1 set of diagnostic intra-articular facet injections or medial branch blocks, defined as \> 75% reduction in pain following diagnostic blocks with local anesthetic (0.5mL of 0.5% bupivacaine OR 0.5 mL of 2% lidocaine).
You may not qualify if:
- Focal neurologic signs or symptoms.
- Radiologic evidence of a symptomatic herniated disc or nerve root impingement related to spinal stenosis.
- Previous radiofrequency ablation treatment for similar symptoms.
- Patient refusal.
- Lack of consent.
- Active systemic or local infections at the site of proposed needle and electrode placement.
- Coagulopathy or other bleeding disorder, current use of anticoagulants or anti-platelet medications.
- Allergy to medications being used for injection procedures (contrast dye, local anesthetic, IV sedative).
- Inability to read English, communicate with staff, or participate in follow up.
- Pregnancy.
- Cognitive deficit.
- Negative response to diagnostic intra-articular facet injections or medial branch blocks, defined as \< 75% reduction in pain following diagnostic blocks with local anesthetic (0.5mL of 0.5% bupivacaine OR 0.5 mL of 2% lidocaine).
- Unstable medical or psychiatric illness.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Northwestern Universitylead
- American Pain Societycollaborator
Study Sites (1)
Anesthesiology Pain Managment Center
Chicago, Illinois, 60611, United States
Related Publications (1)
McCormick ZL, Choi H, Reddy R, Syed RH, Bhave M, Kendall MC, Khan D, Nagpal G, Teramoto M, Walega DR. Randomized prospective trial of cooled versus traditional radiofrequency ablation of the medial branch nerves for the treatment of lumbar facet joint pain. Reg Anesth Pain Med. 2019 Mar;44(3):389-397. doi: 10.1136/rapm-2018-000035.
PMID: 30777903DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
David Walega, MD
Northwestern University Feinberg School of Medicine
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor, Chief, Division of Pain Medicine
Study Record Dates
First Submitted
June 17, 2015
First Posted
June 23, 2015
Study Start
June 1, 2015
Primary Completion
August 1, 2018
Study Completion
August 1, 2018
Last Updated
September 6, 2018
Record last verified: 2018-09
Data Sharing
- IPD Sharing
- Will not share